Business
BioSpectrum Asia
Cytiva opens first Innovation Hub in Korea
Cytiva, a global life sciences leader, has opened its first Innovation Hub in Korea, located in the Songdo Bio-cluster in Incheon.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Caliway Biopharma raises $206 M in Taiwan's biotech largest IPO
Caliway Biopharmaceuticals has announced the successful completion of its initial public offering (IPO) and up-listing from the Emerging Stock Market to the Taipei Exchange.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
SK bioscience invests $3 M in US-based FinaBio specialising in next-gen conjugate vaccine technology
South Korea-based SK bioscience has signed an agreement to acquire a stake in Fina Biosolutions, based in the US, by investing $3 million.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
China's CanSino receives over $17 M to accelerate polio vaccine development
China-based CanSino Biologics Inc. has received an additional financial boost, securing a grant exceeding $17 million to propel its recombinant poliovirus vaccine (VLP-Polio) project forward.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Japan's Astellas and UK-based AviadoBio ink billion dollar deal for gene therapy targeting frontotemporal dementia
UK-based AviadoBio and Japan's Astellas Pharma Inc. have announced an exclusive option and licence agreement for AVB-101, an investigational, AAV-based gene therapy in Phase 1/2 development for patients with frontotemporal dementia with progranulin mutations (FTD-GRN).
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Singapore seizes opportunity to transform healthcare through technology
In response to the convergence of three major developments, namely genomics, artificial intelligence (AI) and the focus on preventive care, the Ministry of Health (MOH) in Singapore is seizing the opportunity to transform healthcare through technology.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
India's CDSCO becomes Affiliate Member of International Medical Device Regulators Forum
To achieve global alignment in its medical device regulatory system, enhance the competitiveness of the domestic industry, and boost transnational prominence, the Central Drugs Standard Control Organisation (CDSCO), under the Ministry of Health and Family Welfare, government of India, applied for Affiliate Membership in the International Medical Device Regulators Forum (IMDRF) in 2024.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
Greater Bay Area International Clinical Trial Institute in Hong Kong to initiate full operations in 2024
The Health Bureau (HHB), Hong Kong government, has announced that after months of preparation with full effort since the Chief Executive put forward in the Policy
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
New Zealand introduces new Mental Health Bill
The Health Ministry in New Zealand has announced that a new Mental Health Bill has been introduced and is now publicly available.
1 min |
BioSpectrum Asia Nov 2024
BioSpectrum Asia
How alarming Is Monkeypox Threat Perception?
As the world finally emerges from the grip of COVID-19, a new threat looms: Mpox (formerly known as Monkeypox).
10+ min |
October 2024
BioSpectrum Asia
Shimadzu launches operations in Mexico
Japan's Shimadzu Corporation has established a subsidiary in Mexico and has begun its activities.
1 min |
October 2024
BioSpectrum Asia
Agilent unveils Biopharma CDx Services Lab to accelerate precision medicine
Agilent Technologies Inc., has announced the launch of its Biopharma CDx Services Lab (BCSL) in Carpinteria, California, US following receipt of California State clinical laboratory license and Clinical Laboratory Improvement Amendments (CLIA) certificate of compliance.
1 min |
October 2024
BioSpectrum Asia
MilliporeSigma launches single-use reactor to accelerate ADCs manufacturing
MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has launched the first single-use reactor specifically designed to manufacture antibody drug conjugates (ADCs). ADCs are a rapidly emerging class of therapeutic agents that can target and selectively kill tumour cells, while protecting healthy ones.
1 min |
October 2024
BioSpectrum Asia
Scopio Labs & Beckman Coulter to distribute digital bone marrow imaging and analysis app
US-based Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company based in Israel that develops digital cell morphology workflow solutions, have jointly announced expansion of its long-term partnership to include a global distribution agreement of Scopio's Full-Field Bone Marrow Aspirate (FF-BMA) Application.
1 min |
October 2024
BioSpectrum Asia
Hong Kong develops next-gen wearable continuous glucose monitoring system
An interdisciplinary research team, including the Faculty of Engineering and Li Ka Shing Faculty of Medicine at The University of Hong Kong (HKU), Zhejiang University, and Guangzhou Medical University, in China, has developed a groundbreaking continuous glucose monitoring (CGM) system which represents a major advancement in wearable health technology and is set to revolutionise diabetes management.
1 min |
October 2024
BioSpectrum Asia
Singapore elevates analysis of genomic data with breakthrough mathematical technique
A novel approach for analysing single-cell RNA sequencing (scRNA-seq) data has been unveiled by researchers at the National University of Singapore (NUS).
1 min |
October 2024
BioSpectrum Asia
Vatroslav Mateljic steps in as General Manager of Takeda Canada
Takeda Canada Inc. has announced the appointment of Vatroslav (Vatro) Mateljic as its new General Manager to lead the Canadian operations of Japan's largest pharmaceutical company.
1 min |
October 2024
BioSpectrum Asia
Bio Duro-Sundia appoints Dr Armin Spura as CEO
BioDuro-Sundia, a leading Contract Research, Development, and Manufacturing Organisation (CRDMO) based in the US and China, has announced the appointment of Dr Armin Spura as its new Chief Executive Officer (CEO).
1 min |
October 2024
BioSpectrum Asia
Singapore's Health Sciences Authority appoints Adj A/ Prof. Raymond Chua as CEO
Adjunct Associate Professor Raymond Chua Swee Boon has been appointed as Chief Executive Officer-Designate of the Health Sciences Authority (HSA), Singapore and will officially assume the Chief Executive Officer (CEO) role from December 13, 2024. Dr Mimi Choong May Ling, the current CEO of HSA, will retire from public service with effect from December 13, 2024.
1 min |
October 2024
BioSpectrum Asia
Novotech appoints Dr Yooni Kim as Managing Director for APAC region
Novotech, the leading global biotech Contract Research Organisation (CRO), has announced the appointment of Dr Yooni Kim as a new Executive position of Managing Director for the Asia-Pacific (APAC) region. The establishment of the Managing Director APAC role is a significant step, aligning Novotech’s operations across key regions, including the United States, Europe, Mainland China, and APAC.
1 min |
October 2024
BioSpectrum Asia
Amit Mookim steps in as CEO of Immuneel Therapeutics
India-based Immuneel Therapeutics, a pioneering cell and gene therapy platform, has announced the appointment of Amit Mookim as its new Chief Executive Officer (CEO).
1 min |
October 2024
BioSpectrum Asia
Tanvex BioPharma appoints Stephen Lam as CEO
Tanvex BioPharma, Inc., Taiwan-based biosimilar-focused biopharmaceutical company and a contract development and manufacturing organisation (CDMO,) has announced that its Board of Directors has appointed Stephen Lam as the company's Chief Executive Officer (CEO).
1 min |
October 2024
BioSpectrum Asia
Zuellig Pharma: A Sustainable Approach to Healthcare Access Through Innovative Solutions
The equitable distribution of medicines and their accessibility are critical to the resilience of the healthcare system.
4 min |
October 2024
BioSpectrum Asia
Korea announces first joint degree programme in AI in partnership with US
Korea Advanced Institute of Science and Technology (KAIST) and New York University, US have signed a Memorandum of Understanding (MoU) to introduce a graduate programme for a joint degree in the field of artificial intelligence (AI).
1 min |
October 2024
BioSpectrum Asia
TriMedSoc Alliance renews collaboration, uniting Singapore medical students
Student bodies from Singapore’s three medical schools renewed their partnership, three years after the TriMedSoc Alliance was first established.
1 min |
October 2024
BioSpectrum Asia
Bharat BioEconomy to touch $30 trillion by 2050: IBER 2024
“The Indian BioEconomy is projected to rise to $30 trillion by 2050, within a global economy valued at $228 trillion, representing a significant increase in its economic share from 4 to 13 per cent,” according to the India BioEconomy Report (IBER 2024), prepared for 'Make In India Facilitation Cell for Biotechnology' of Biotechnology Industry Research Assistance Council (BIRAC), by Association of Biotechnology Led Enterprises (ABLE).
4 min |
October 2024
BioSpectrum Asia
Why Cyber-resilience is Crucial
In recent years, ransomware attacks have become more regular, stealthy, and expensive. They have also been developing swiftly.
4 min |
October 2024
BioSpectrum Asia
"ICMR has committed to funding all aspects of Phase I trials of Zika vaccine"
Hyderabad-based Indian Immunologicals Ltd (IIL) has signed an agreement with the Indian Council of Medical Research (ICMR) on September 12 for clinical development of India’s first codon de-optimised live attenuated Zika vaccine.
2 min |
October 2024
BioSpectrum Asia
"Developing capabilities to profile the next gen compounds in new modalities is expected to drive preclinical CRO growth"
The preclinical Contract Research Organisation (CRO) sector in India is witnessing massive transformation with huge investments being made in this sector by domestic and multinational players to cater to the global needs.
7 min |
October 2024
BioSpectrum Asia
"The ongoing alignment of clinical trial regulations across APAC with global standards is significant"
Celebrating 25 years of ground-breaking technological innovation across more than 34,000 trials and 10 million patients, Medidata, a Dassault Systèmes brand headquartered in New York City and having strong presence in the United Kingdom and the Asia Pacific (APAC) region offers industry-leading expertise, analyticspowered insights, and the largest patient-level historical clinical trial data set in the world.
5 min |